Primary Glaucoma

Primary glaucoma is an inherited ocular condition in dogs where elevated intraocular pressure develops due to genetically determined abnormalities of the eye's drainage structures, without any other underlying eye disease triggering the pressure elevation. This condition represents one of the most significant inherited eye diseases in dogs, affecting numerous breeds with varying prevalence rates and accounting for a substantial proportion of canine blindness cases each year. The term primary distinguishes this form from secondary glaucoma, where pressure elevation results from another identifiable eye condition such as inflammation, lens displacement, or tumors. In primary glaucoma, the drainage dysfunction is intrinsic to the eye's construction, determined by the dog's genetic makeup.

The genetic basis of primary glaucoma involves inherited abnormalities in the development or structure of the iridocorneal angle, the region where aqueous humor exits the eye. These abnormalities, collectively termed goniodysgenesis or pectinate ligament dysplasia, create resistance to normal fluid outflow that eventually overwhelms the drainage system's capacity. Some breeds inherit narrow or closed drainage angles, while others have abnormal pectinate ligament structure that impedes flow through otherwise open angles. The specific genetic mutations responsible have been identified in some breeds, while in others the precise genetic basis remains under investigation. Regardless of the specific mutation, the end result is similar: inevitable progression toward drainage failure and pressure elevation.

Primary glaucoma profoundly impacts affected dogs and their owners, often striking without warning and progressing rapidly to blindness without aggressive intervention. The condition typically manifests in middle-aged dogs, though the underlying anatomical predisposition is present from birth. Many dogs appear completely normal until the drainage system's reserve capacity is exhausted and pressure suddenly rises. This acute presentation often affects one eye first, but the fellow eye faces extremely high risk of developing glaucoma as well, typically within one to two years. The bilateral nature of inherited predisposition means that managing primary glaucoma involves not only treating the affected eye but proactively protecting the eye that appears normal.

Treatment of primary glaucoma requires lifelong commitment to medical management, often supplemented by surgical intervention to preserve remaining vision. Because the genetic defect cannot be corrected, treatment focuses on compensating for impaired drainage by reducing fluid production and enhancing whatever outflow capacity remains. The goals of treatment include maintaining comfortable intraocular pressure, preserving vision as long as possible, and preventing or delaying involvement of the fellow eye. Success requires dedication from owners, regular monitoring by veterinary professionals, and often collaboration with veterinary ophthalmologists who specialize in these complex cases. Understanding the hereditary nature of primary glaucoma is essential for making informed decisions about breeding dogs in affected breeds.

The primary cause of breed-related glaucoma is inherited malformation of the aqueous humor drainage apparatus, particularly the iridocorneal angle where fluid exits the eye. Normal eyes have a wide, open drainage angle with properly developed pectinate ligaments that span from the iris base to the peripheral cornea, allowing aqueous humor to flow through to the trabecular meshwork and out of the eye. In dogs with primary glaucoma, these structures fail to develop properly, resulting in narrowed angles, sheets of tissue covering the drainage area, or dysplastic pectinate ligaments that impede outflow. This structural predisposition is established during fetal development based on the genetic instructions encoded in the dog's DNA.

Genetic inheritance patterns for primary glaucoma vary among breeds and may include autosomal recessive, autosomal dominant with variable penetrance, or complex polygenic inheritance involving multiple genes. In some breeds, specific mutations have been identified that allow definitive genetic testing. For example, mutations in the ADAMTS10 gene cause primary open-angle glaucoma in Beagles, and similar discoveries have been made in other breeds. However, for many breeds, the precise genetic basis remains undetermined, and diagnosis relies on clinical examination rather than DNA testing. The strong hereditary component is evident from the dramatically elevated prevalence in certain breeds compared to the general dog population and the clustering of cases within specific bloodlines.

Environmental factors play minimal direct role in causing primary glaucoma, though they may influence when clinical disease manifests in a genetically predisposed individual. The anatomical abnormality is present from birth and does not result from any external exposure or lifestyle factor. However, factors that stress the eye's drainage capacity, such as age-related changes in drainage efficiency, episodes of mild inflammation, or pupil dilation in dark conditions, may precipitate clinical disease in eyes that have been compensating for marginal drainage function. These triggering factors do not cause glaucoma in dogs without genetic predisposition but may determine timing in those who carry the genetic defect.

Risk factors for primary glaucoma center on breed and family history, with certain breeds showing prevalence rates many times higher than mixed-breed populations. American and English Cocker Spaniels demonstrate particularly high incidence, with studies finding the majority of individuals have some degree of goniodysgenesis. Basset Hounds show similarly elevated rates. Chow Chows, Shar Peis, and Arctic breeds including Siberian Huskies and Samoyeds face increased risk. Terrier breeds including Cairn Terriers and Wire Fox Terriers are commonly affected. Within breeds, certain bloodlines show dramatically higher incidence than others, reflecting concentration of risk alleles through breeding practices.

The mechanism of disease development in primary glaucoma involves progressive failure of a drainage system that was never able to function optimally. Dogs with goniodysgenesis may maintain normal pressure for years through compensatory mechanisms that increase outflow through alternative pathways or reduce aqueous production. Age-related changes gradually reduce this compensatory reserve, and eventually a threshold is crossed where inflow exceeds outflow capacity. Pressure rises, initially perhaps only modestly, but progressive damage to the remaining functional drainage structures creates a self-perpetuating cycle of worsening outflow resistance. This explains why primary glaucoma typically manifests in middle age rather than at birth, despite the genetic defect being present lifelong.

Early warning signs of primary glaucoma are frequently subtle and easily overlooked until acute pressure elevation occurs. Owners may notice mild intermittent redness of the eyes that resolves spontaneously, occasional squinting or sensitivity to light, or subtle changes in pupil appearance. Some dogs show behavior suggesting mild headache-like discomfort, such as rubbing the head or avoiding bright light. Vision changes may occur gradually, with dogs seeming slightly less confident in dim conditions or occasionally missing visual cues. These vague early signs often prompt no action because they resolve on their own, representing brief pressure fluctuations that the eye temporarily compensates for before the next episode.

Common symptoms of primary glaucoma often present acutely when the drainage system suddenly fails completely. The classic presentation involves sudden onset of a painful, red, cloudy eye with a dilated pupil that does not respond to light. Owners frequently report that their dog was completely normal one day and presented with an obviously abnormal eye the next morning. The redness results from congestion of surface blood vessels struggling to drain against elevated pressure. Corneal cloudiness develops as fluid is forced into the corneal tissue under pressure. The dilated, fixed pupil reflects damage to the iris sphincter muscle and the nerves controlling pupillary response. This acute presentation constitutes an emergency because extremely high pressures can destroy remaining vision within hours.

Behavioral changes accompanying primary glaucoma reflect both visual impairment and pain from elevated intraocular pressure. Dogs with acute glaucoma often appear depressed, reluctant to eat, and withdrawn from normal activities. They may hide, seek quiet dark places, or resist having their head touched. Some dogs vocalize or whimper, indicating distress. Changes in activity level are common, with affected dogs reluctant to play, walk, or engage in normal behaviors. As vision deteriorates, dogs may bump into objects, startle easily, and become disoriented in familiar environments. These behavioral changes may actually precede obvious ocular signs, providing observant owners an early warning that something is wrong.

Physical signs visible during examination of dogs with primary glaucoma vary with the stage and severity of disease. In acute presentations, the affected eye appears obviously abnormal with prominent redness, corneal cloudiness ranging from slight haze to dense opacity, and a dilated pupil. Eye enlargement may develop if pressure remains elevated over days to weeks. In more chronic presentations, enlargement may be the most obvious change, with gradual globe expansion occurring as elastic tissues stretch under sustained pressure. Comparison with the fellow eye often reveals asymmetry in size, pupil diameter, or clarity. Advanced cases may show lens displacement, visible optic nerve changes, or complete blindness with absent responses to visual stimuli.

Symptom progression in primary glaucoma follows variable patterns depending on whether the onset is acute or chronic and how effectively treatment controls pressure. Acute presentations may progress from normal to blind within hours if extremely high pressures occur and treatment is delayed. More gradual onset allows time for adaptation but steadily erodes visual function as pressure damage accumulates. Without treatment, progression to complete blindness is inevitable in nearly all cases. With treatment, progression can often be slowed dramatically, but most affected eyes eventually lose functional vision over months to years. The rate of progression varies among individuals based on pressure levels achieved with treatment and the extent of damage present at diagnosis.

Emergency symptoms requiring immediate veterinary attention include signs of acute severe pressure elevation. Sudden onset of severe eye redness, intense cloudiness, obvious pain, and behavioral changes constitute an emergency that should prompt same-day veterinary evaluation, ideally within hours. A visibly enlarged or bulging eye indicates sustained severe pressure and represents an emergency even without acute pain signs. Signs of corneal ulceration, including a white spot on the eye surface, require urgent attention because ulcers progress rapidly and can perforate. Any sudden worsening in a dog with known glaucoma warrants immediate evaluation, as acute spikes superimposed on chronic disease can rapidly destroy remaining vision that aggressive intervention might preserve.

Initial examination for suspected primary glaucoma begins with comprehensive history taking and physical assessment. The veterinarian will ask about the onset and duration of observed changes, previous eye problems, the dog's breed background, and any family history of eye disease. Physical examination includes evaluation of eye appearance, pupil size and symmetry, corneal clarity, and signs of pain or discomfort. Both eyes are carefully compared because primary glaucoma often presents unilaterally initially while the fellow eye carries the same genetic predisposition. The dog's behavior during examination provides information about vision status in each eye. This initial assessment guides subsequent diagnostic testing.

Tonometry is the essential diagnostic test for confirming glaucoma through objective measurement of intraocular pressure. Modern applanation tonometers designed for veterinary use provide accurate pressure readings quickly and with minimal patient discomfort. Normal canine intraocular pressure ranges approximately 10 to 25 mmHg, though values vary somewhat between instruments and individuals. In acute primary glaucoma, pressures often exceed 40 to 60 mmHg and may reach extremely high levels that clearly indicate emergency. More moderate elevations in the 30s may occur with chronic or treated glaucoma. Serial measurements over time help distinguish sustained elevation from transient fluctuations that can occur in normal eyes.

Gonioscopy examination provides crucial information for diagnosing primary glaucoma and distinguishing it from secondary causes. Using specialized lenses, the examiner directly visualizes the iridocorneal angle where aqueous humor drainage occurs. Characteristic findings in primary glaucoma include narrowed or closed angles, abnormal pectinate ligament strands that appear thickened or sheeted, and absence of visible trabecular meshwork. Gonioscopy of the fellow eye is equally important because finding similar abnormalities confirms the primary nature of the disease and identifies the second eye as being at very high risk. Documentation of gonioscopy findings establishes baselines for monitoring and provides essential information for genetic counseling.

Additional diagnostic testing helps characterize disease severity and identify concurrent problems. Fundoscopic examination evaluates the optic nerve head and retina for evidence of pressure damage, including optic disc cupping, retinal vessel changes, and generalized retinal degeneration. When corneal cloudiness prevents direct visualization, ocular ultrasound assesses posterior segment structures. Electroretinography objectively measures retinal function to help determine visual prognosis. Blood work may be recommended to establish baselines before initiating medications with potential systemic effects. Referral to a veterinary ophthalmologist provides access to specialized expertise, particularly valuable for confirming diagnosis, performing gonioscopy, and developing comprehensive treatment plans for these complex lifelong conditions.

Emergency treatment for acute primary glaucoma focuses on rapidly lowering dangerously elevated pressure to preserve vision. Intravenous mannitol, an osmotic agent, draws fluid from the eye and can dramatically reduce pressure within hours. Topical carbonic anhydrase inhibitors and prostaglandin analogs are applied to reduce aqueous production and enhance outflow. Systemic carbonic anhydrase inhibitors may be added for severe cases. Pain management is essential because high pressures cause significant discomfort. This emergency treatment typically occurs in a veterinary hospital with close monitoring until pressure stabilizes. The goal is to lower pressure quickly enough to prevent irreversible optic nerve damage while planning for long-term management.

Medical management forms the cornerstone of ongoing primary glaucoma treatment and typically involves multiple topical medications applied to the affected eye several times daily. Prostaglandin analogs such as latanoprost represent first-line therapy, enhancing aqueous outflow through the uveoscleral pathway. Carbonic anhydrase inhibitors like dorzolamide reduce aqueous production by the ciliary body. Beta-blockers including timolol also decrease fluid production. Most dogs require combination therapy using multiple medication classes to achieve adequate pressure control. Medication regimens often require two to four applications daily, demanding significant owner commitment for optimal outcomes. Regular pressure monitoring guides medication adjustments to optimize control.

Surgical intervention becomes necessary when medical therapy proves insufficient or when medication burden becomes unsustainable. Cyclophotocoagulation uses laser energy to destroy portions of the ciliary body, reducing aqueous production at its source. Transscleral approaches apply laser through the sclera, while endoscopic techniques allow more precise targeting under direct visualization. Gonioimplant surgery places drainage devices that shunt fluid from inside the eye to a subconjunctival reservoir, bypassing the dysfunctional natural drainage system. These procedures can provide long-term pressure reduction when successful but carry risks including inflammation, infection, and potential need for repeat procedures. Selection among surgical options depends on individual patient factors and available expertise.

Supportive care complements primary pressure-lowering treatments and addresses comfort, overall eye health, and quality of life. Anti-inflammatory medications help control chronic low-grade inflammation that accompanies glaucoma and contributes to ongoing drainage deterioration. Pain management ensures patient comfort because chronic pressure elevation causes discomfort that dogs may not obviously display. Lubricating eye drops maintain corneal health, particularly important in eyes with reduced blink reflexes or exposure due to enlargement. Protection from trauma becomes increasingly important as damaged eyes become more vulnerable to injury.

Alternative and complementary treatments may provide supplemental support alongside conventional therapy. Some owners pursue nutritional supplements with antioxidant properties, though direct evidence for benefit in canine glaucoma is limited. Acupuncture has been used primarily for pain management rather than pressure control. Physical therapy and stress reduction may support overall well-being. These approaches should complement rather than replace proven medical and surgical treatments and should be discussed with the veterinary care team to ensure they do not interfere with primary therapy.

Treatment decisions involve careful consideration of visual potential, patient comfort, owner capabilities, and financial realities. Eyes with remaining vision warrant aggressive treatment to preserve that vision. However, when an eye becomes blind and painful despite treatment efforts, enucleation often provides the best quality of life outcome by permanently eliminating discomfort and intensive medication requirements. Prophylactic treatment of the fellow eye when one eye develops primary glaucoma can significantly delay disease onset in that eye. Regular reassessment of treatment goals ensures that management remains appropriate as the condition evolves over time.

Recovery timeline following treatment for primary glaucoma depends on the intervention type and disease stage at treatment initiation. Dogs beginning medical management may achieve pressure stabilization within days to weeks, though optimizing the medication regimen often requires several months of adjustments based on pressure monitoring. Following surgical procedures, initial healing typically spans two to four weeks with gradual assessment of treatment success over subsequent months. Recovery from acute glaucoma emergencies involves both physical recovery from the acute insult and psychological adjustment to any vision loss that occurred. True recovery in the sense of cure is not possible because the genetic defect persists, making ongoing management rather than recovery the more accurate framework.

Post-treatment care requirements include rigorous medication compliance and regular monitoring. Pressure checks should occur weekly initially after establishing or adjusting treatment, then extend to monthly and eventually quarterly as stability is confirmed. Eye examinations assess for complications and monitor the unaffected eye for early signs of developing glaucoma. Owners must master proper medication administration and maintain consistent dosing schedules, as missed doses allow pressure fluctuations that erode treatment gains. Activity restriction may be necessary following surgery but is not typically required for medically managed patients. Communication with the veterinary team about any observations or concerns allows timely intervention when needed.

Prognosis factors in primary glaucoma include the pressure level achieved with treatment, extent of damage present at diagnosis, compliance with medication protocols, and bilateral progression. Dogs diagnosed before significant vision loss and achieving good pressure control may maintain useful vision for years. Those presenting with advanced damage or responding poorly to treatment face more guarded visual prognosis. Even with optimal management, most eyes with primary glaucoma eventually lose functional vision as cumulative damage exceeds the optic nerve's capacity. The fellow eye's status significantly impacts overall prognosis, as involvement is expected in most cases.

Long-term outlook requires acceptance that primary glaucoma is a lifelong progressive condition rather than a curable disease. Even well-controlled eyes face gradual deterioration over time, though the rate of decline can be dramatically slowed compared to untreated disease. Dogs that become blind often adapt remarkably well, particularly when vision loss occurs gradually and they develop compensatory strategies using other senses. Quality of life can remain excellent with appropriate owner commitment and veterinary support. Ongoing care relationships with the veterinary team enable monitoring, treatment adjustment, and support throughout the dog's life.

Primary prevention of breed-related glaucoma depends critically on responsible breeding practices aimed at reducing disease incidence in future generations. Dogs diagnosed with primary glaucoma should never be bred, as they carry genetic mutations that will be passed to offspring. Parents and siblings of affected dogs should be considered at elevated risk and either excluded from breeding or bred only with extreme caution after comprehensive screening. Breeding registries that document eye examination results help identify bloodlines with higher or lower risk. Selection for mating partners with normal gonioscopy findings from families without glaucoma history gradually reduces population-level disease incidence over generations.

Genetic screening and testing provide powerful tools for prevention in breeds where causative mutations have been identified. DNA testing can identify carriers who may have normal eyes clinically but carry mutations they could pass to offspring. Testing breeding stock before mating enables informed decisions that avoid producing affected puppies. Even in breeds without available DNA tests, gonioscopy screening identifies dogs with drainage angle abnormalities that predict increased risk. Breed clubs and registries that require or encourage such screening before breeding drive adoption of these practices. Supporting ongoing genetic research advances the development of new tests for additional breeds.

Nutritional prevention strategies for primary glaucoma remain limited because the condition results from inherited structural defects rather than nutritional factors. However, maintaining optimal overall health through quality nutrition supports the eye's ability to compensate for anatomical limitations as long as possible. Avoiding obesity reduces general metabolic stress and supports cardiovascular health that may indirectly benefit ocular circulation. Antioxidant-rich diets theoretically support nerve tissue health, though evidence for direct glaucoma prevention benefit is lacking. No specific dietary intervention has been proven to prevent primary glaucoma in genetically predisposed dogs.

Health maintenance through regular veterinary care enables early detection when prevention fails. Annual comprehensive eye examinations are recommended for all dogs in predisposed breeds, with more frequent examinations for those with gonioscopy abnormalities or family history. Tonometry screening detects elevated pressure before obvious clinical signs develop. Baseline gonioscopy in young adults establishes individual risk profiles. These screening practices do not prevent glaucoma from developing but enable earlier intervention that improves outcomes when disease does occur.

Early intervention when one eye develops primary glaucoma can delay or prevent involvement of the fellow eye. Prophylactic treatment of the normal-appearing eye with pressure-lowering medications has been shown to significantly extend the time before that eye develops clinical disease. Regular pressure monitoring detects early increases before they reach damaging levels. Some veterinary ophthalmologists recommend prophylactic laser treatment to the fellow eye based on gonioscopy findings suggesting high risk. These preventive measures for the second eye represent some of the most impactful interventions available in primary glaucoma management.

Daily management of dogs with primary glaucoma centers on consistent medication administration and vigilant monitoring for changes in condition. Most dogs require multiple eye drops given two to four times daily, requiring a reliable routine integrated into owner and dog schedules. Proper administration technique is essential, including warming refrigerated drops, allowing adequate intervals between different medications, ensuring the drop actually enters the eye, and avoiding contaminating the bottle tip. Many owners find medication reminder apps or phone alarms helpful for maintaining consistency. Keeping a log of administration times and any observations about the eye's appearance provides valuable information for veterinary appointments and helps identify patterns.

Home environment modifications support dogs experiencing vision loss from primary glaucoma. Maintaining consistent furniture arrangements allows visually impaired dogs to navigate confidently using spatial memory. Blocking access to stairs or other hazards when unsupervised prevents accidents. Night lights help dogs with partial vision navigate in dim conditions. Keeping food and water bowls in consistent locations reduces confusion. Textured rugs or mats can serve as tactile landmarks for important locations. When changes must be made, introducing them gradually while supervising the dog helps them adapt their mental maps without anxiety.

Quality of life for dogs with primary glaucoma can remain excellent despite visual limitations when owners provide appropriate support and adjust expectations. Dogs adapt remarkably well to gradual vision loss, increasingly relying on their superior senses of smell and hearing. Maintaining normal activities to the extent possible supports psychological well-being. Verbal cues and consistent commands become increasingly important for communication. Scented toys and treat puzzles provide mental stimulation independent of vision. Social interaction with family members and other pets continues to enrich daily life. The human-animal bond often deepens as owner and dog develop new ways of connecting.

Monitoring and ongoing veterinary care remain essential throughout the course of primary glaucoma. Owners must learn to recognize signs of pressure elevation or treatment failure, including increased cloudiness, redness, squinting, pupil changes, or behavioral indicators of discomfort. Any sudden changes warrant prompt veterinary evaluation because acute spikes can rapidly destroy remaining vision. Scheduled rechecks, typically every two to four months for stable patients, allow pressure monitoring, medication effectiveness assessment, and early detection of complications. Both eyes require monitoring because the fellow eye faces high risk of developing disease.

Caregiver support helps owners manage the emotional and practical demands of caring for a dog with primary glaucoma. Connecting with communities of owners whose dogs have similar conditions provides practical tips and emotional support. Understanding that management goals focus on comfort and quality of life rather than cure helps set realistic expectations. Financial planning for long-term care needs, including emergency reserves for crises, reduces stress when decisions must be made quickly. The veterinary team serves as partners throughout the journey, providing medical expertise, emotional support, and guidance for difficult decisions about treatment intensity and end-of-life care when that time comes.

High-risk breeds for primary glaucoma include several with dramatically elevated prevalence due to inherited goniodysgenesis. American and English Cocker Spaniels show among the highest rates, with studies finding drainage angle abnormalities in the majority of individuals examined. Basset Hounds inherit goniodysgenesis at very high frequency and commonly develop clinical glaucoma in middle age. Chow Chows and Shar Peis demonstrate significant predisposition, with their distinctive facial structure potentially contributing to angle abnormalities. Siberian Huskies and other Arctic breeds face increased susceptibility. Beagles have well-characterized genetic glaucoma with identified causative mutations. These breeds warrant routine screening of breeding stock and regular monitoring of pet dogs for early disease detection.

Moderate-risk breeds and categories encompass numerous additional breeds showing elevated incidence compared to mixed-breed populations. Terrier breeds as a group demonstrate increased glaucoma susceptibility, with Cairn Terriers, Wire Fox Terriers, Scottish Terriers, and Jack Russell Terriers among those commonly affected. Spaniel breeds beyond Cockers, including English Springer Spaniels, show elevated risk. Toy breeds including Toy and Miniature Poodles experience higher rates than their small size might suggest. Great Danes and other giant breeds show increased prevalence. Welsh Corgis and Boston Terriers face elevated risk. Mixed-breed dogs with ancestry from high-risk breeds may inherit predisposition, making family history relevant even for non-purebred dogs.

Screening recommendations for breeds at risk emphasize examination by veterinary ophthalmologists with expertise in gonioscopy. The Canine Eye Registration Foundation and Orthopedic Foundation for Animals maintain databases of eye examination results that help track breed-wide prevalence. Dogs of high-risk breeds intended for breeding should undergo gonioscopy examination before mating, with results submitted to registries. Annual comprehensive eye examinations including tonometry are recommended for all dogs in predisposed breeds. Dogs from lines with known glaucoma history warrant particularly close monitoring. Prospective puppy buyers should request documentation of parental eye examinations when purchasing puppies from breeds at risk for primary glaucoma.

Commonly co-occurring conditions with primary glaucoma include other ocular diseases that may share genetic underpinnings or develop secondary to glaucomatous damage. Cataracts frequently accompany glaucoma, either as independent age-related or breed-related conditions or developing secondary to chronic intraocular inflammation and metabolic changes associated with elevated pressure. Lens luxation can both cause and result from glaucoma, with zonular fiber weakening from chronic pressure allowing lens displacement that may then exacerbate drainage obstruction. Retinal degeneration beyond that directly caused by glaucomatous optic nerve damage may occur concurrently in breeds predisposed to both conditions. Managing dogs with multiple ocular conditions requires coordination of treatments and prioritization based on impact on vision and comfort.

Conditions with similar symptoms must be differentiated during diagnostic evaluation to ensure appropriate treatment. Secondary glaucoma from uveitis, lens luxation, intraocular tumors, or trauma presents similarly to primary glaucoma but requires addressing the underlying cause in addition to pressure management. Anterior uveitis causes redness, cloudiness, and pain that may mimic glaucoma, though pressure is typically low rather than elevated. Acute anterior lens luxation can present with sudden redness and pain. Corneal diseases causing cloudiness may be confused with glaucoma-related corneal edema. Comprehensive examination including tonometry and gonioscopy differentiates primary glaucoma from these other conditions requiring different management approaches.

Potential complications of primary glaucoma extend beyond progressive vision loss to include structural changes that impact comfort and quality of life. Lens luxation occurs when zonular fibers weakened by chronic pressure elevation fail, potentially causing secondary acute glaucoma if the lens obstructs aqueous outflow. Corneal ulceration may develop in enlarged eyes where lid closure is inadequate or corneal exposure occurs. Globe rupture represents a risk in severely enlarged, fragile eyes subjected to trauma. Phthisis bulbi, shrinkage of the globe, may occur in end-stage disease. These complications often necessitate surgical intervention and significantly impact quality of life. Understanding potential complications helps owners prepare for disease progression and make timely treatment decisions.